|
| Any one going long? Any one with the balls to short? I want to add, but I don't like the way the board is handling this. I think the buying opportunity is during peak drama of a board shake up myself.
Q3 earnings were really strong all around. Revenue YoY grew 103% to $115B. Q3 free cash flow grew 98.2% YoY to $43B. GAAP net Income $65.3B.
Its fair to criticize the guarantees. Truth is, worst case a liability of $120B doesn't kill this company, but it is a risk to share valuation. Nevermind that in that scenerio, revenue would presumably be suffering.
NVDA is a machine, but valuing the machine is where the debate is. And the machine just lost it's founder / captain... at least for now. | |
|